Nico.lab, a ground-breaking Dutch health-tech venture, is getting ready for an IPO in Australia as it raised €3 million from Australian investors earlier this year. The IPO is planned for the beginning of 2019. Besides the Australian investment, the healthcare company is keen on a market entry in North America.
Merel Boers, Chief Research Officer at Nico.lab: “We are very pleased with the great interest in our product that combines the latest clinical research results with state-of-the-art AI technology. This movement shows that an impact can be made in healthcare. We want to work hard on further expanding StrokeViewer in the coming years to help more patients.”